Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Integrated Management of Placenta Accreta Spectrum in the Modern Era: combining obstetric imaging with oncological surgical skills'


Professor Sally CollinsProfessor Sally L. Collins is a Consultant Obstetrician subspecializing in Feto-Maternal Medicine at the John Radcliffe Hospital and a Professor of Obstetrics in the Nuffield Department of Women’s and Reproductive Health, University of Oxford.

Sally graduated in Medicine from the University of Oxford and specialized in Obstetrics and Gynaecology, training within the Oxford region during which time she completed a DPhil in Obstetric Ultrasound. Sally is currently a Consultant Obstetrician in a busy NHS Trust and has set up the Oxford FMU tertiary referral Placenta Clinic. 

She is highly research active having authored over 100 journal articles, filed three patents and won several international research awards. She currently holds several grants including from the NIHR and Sir Jules Thorn Trust to develop a fully automated first trimester ultrasound screening tool for fetal growth restriction. Using machine learning techniques her team pioneered the first fully automated method for estimating placental morphology and vascularity from a 3D ultrasound image. It is hoped that this will form the basis of a first trimester multifactorial screening test for adverse pregnancy outcomes such as fetal growth restriction and pre-eclampsia.

Sally is also world renown for her expertise in placenta accreta spectrum (PAS) and is currently working with NHS England to develop a national network for the diagnosis and management of PAS having co-authored the RCOG and FIGO guidelines on diagnosis and management of PAS. She is Chairperson elect of the International Society for PAS and is the lead author on their recent evidence-based guidelines. She is a founder member of the Oxford Placenta Accreta team ( and continues to strive to improve the outcomes for women affected by this rare, but complex and potentially lethal condition.


Mr Hooman Soleymani majd

Mr Hooman Soleymani majd started his Obstetrics and Gynaecology career in London, before moving to Oxford and completing his structured postgraduate training programme. During the course of training he obtained membership of the Royal College of Obstetricians and Gynaecologists (MRCOG), which culminated in a Certificate of Completion of Training (CCT) in Obstetrics and Gynaecology. Hooman then completed a further three years of Sub-Specialty Training in Gynaecological Oncology at the Churchill Cancer Centre in Oxford. He is a BSCCP accredited Colposcopist and trainer, as well as a member of the British Gynaecological Cancer Society (BGCS). He is a Consultant in Gynaecological Oncology at the Churchill Hospital and have been in post since 2016.

Hooman has a special interest in developing new surgical techniques in ultra-radical surgery for advanced ovarian cancer and radical pelvic exenteration operations. His skill set includes upper abdominal surgery, liver mobilisation and diaphragmatic reconstruction. He also has a particular interest in treating patients with Placenta Accreta Spectrum (PAS). He is a founding member and surgical lead for the OxPAT group. He is also a member of the Oxford Sarcoma team. 

Hooman is currently collaborating with Professor Sarosh Irani in the Nuffield Department of Clinical Neurosciences and Dr Adam Al-Diwani in the Department of Psychiatry on auto-antibody mediated neurological diseases. 

He is actively involved in teaching registrars/fellows and medical students from Oxford University. He has published numerous papers and been an invited speaker at a number of international congresses. He is on the editorial board of Current Problems in Cancer: Case Reports, Gynecology and Pelvic Medicine (GPM) and the Journal of Obstetrics, Gynecology and Cancer Research (JOGCR). He is also a reviewer for Cereus, BMJ case reports, European Journal of Gynaecology Oncology (EJGO) and Frontiers in Oncology.


All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.